K Erhardt

628 total citations
24 papers, 520 citations indexed

About

K Erhardt is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, K Erhardt has authored 24 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Oncology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in K Erhardt's work include Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (8 papers) and DNA Repair Mechanisms (3 papers). K Erhardt is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (8 papers) and DNA Repair Mechanisms (3 papers). K Erhardt collaborates with scholars based in Sweden and United States. K Erhardt's co-authors include Gert Auer, Anders Fallenius, Gun Forsslund, A. Zetterberg, B. Lagerlöf, Birgitta Sundelin, Eva Månsson‐Brahme, Ulrik Ringborg, John Carstensen and Lars Erik Rutqvist and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and Breast Cancer Research and Treatment.

In The Last Decade

K Erhardt

24 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Erhardt Sweden 12 274 219 124 101 95 24 520
Soper Jt United States 4 317 1.2× 143 0.7× 72 0.6× 214 2.1× 50 0.5× 8 627
F Rilke Italy 9 304 1.1× 211 1.0× 297 2.4× 154 1.5× 135 1.4× 20 721
T S Frank United States 7 111 0.4× 146 0.7× 187 1.5× 200 2.0× 67 0.7× 8 602
Sydney D. Finkelstein United States 10 386 1.4× 108 0.5× 166 1.3× 199 2.0× 99 1.0× 10 658
S Shousha United Kingdom 11 228 0.8× 230 1.1× 202 1.6× 148 1.5× 176 1.9× 25 603
Ricardo S. Cajulis United States 13 153 0.6× 137 0.6× 144 1.2× 156 1.5× 217 2.3× 32 559
Betsy O. Spaulding United States 16 312 1.1× 216 1.0× 84 0.7× 348 3.4× 147 1.5× 19 725
Georg E. Feichter Switzerland 14 262 1.0× 154 0.7× 49 0.4× 167 1.7× 159 1.7× 22 626
I Ruschenburg Germany 13 187 0.7× 79 0.4× 64 0.5× 186 1.8× 90 0.9× 41 464
J M Nesland Norway 9 211 0.8× 196 0.9× 141 1.1× 106 1.0× 68 0.7× 13 450

Countries citing papers authored by K Erhardt

Since Specialization
Citations

This map shows the geographic impact of K Erhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Erhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Erhardt more than expected).

Fields of papers citing papers by K Erhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Erhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Erhardt. The network helps show where K Erhardt may publish in the future.

Co-authorship network of co-authors of K Erhardt

This figure shows the co-authorship network connecting the top 25 collaborators of K Erhardt. A scholar is included among the top collaborators of K Erhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Erhardt. K Erhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Månsson‐Brahme, Eva, John Carstensen, K Erhardt, et al.. (1994). Prognostic factors in thin cutaneous malignant melanoma. Cancer. 73(9). 2324–2332. 83 indexed citations
2.
Auer, Gert, et al.. (1991). Nuclear DNA analyses in archival material from primary malignant melanoma. A pilot study.. PubMed. 13(5). 335–42. 4 indexed citations
3.
Erhardt, K, Claes Silfverswärd, & Gert Auer. (1990). Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.. PubMed. 9(5). 1325–30. 5 indexed citations
4.
Erhardt, K, et al.. (1988). Analysis of DNA distribution in Kaposi's sarcoma in patients with and without the acquired immune deficiency syndrome.. PubMed. 10(1). 16–20. 8 indexed citations
5.
Strander, Hans, J. Boëthius, K Erhardt, et al.. (1987). Does Successful Interferon Treatment of Tumor Patients Require Life-Long Treatment?. Journal of Interferon Research. 7(5). 619–626. 17 indexed citations
6.
Yoneyama, Kihei, K Erhardt, Gert Auer, et al.. (1987). Nuclear DNA Content in Squamous Cell Carcinoma, Small Cell Carcinoma, and Bronchiolo-Alveolar Carcinoma of the Lung. American Journal of Clinical Oncology. 10(4). 330–334. 6 indexed citations
7.
Nobin, Anders, K Erhardt, Gert Auer, Sture Falkmer, & H. Mårtensson. (1987). Nuclear DNA patterns and survival in metastasizing ileal carcinoids. World Journal of Surgery. 11(3). 372–377. 8 indexed citations
8.
Goldman, Sven, Gert Auer, K Erhardt, & U. Seligson. (1987). Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Diseases of the Colon & Rectum. 30(6). 444–448. 38 indexed citations
9.
Askensten, U, et al.. (1987). Comparison between slide and flow cytophotometric DNA measurements in breast tumors.. PubMed. 9(2). 138–46. 31 indexed citations
10.
Erhardt, K, Gert Auer, Anders Fallenius, et al.. (1986). Prognostic Significance of Nuclear DNA Analysis in Histological Sections in Mammary Carcinoma. American Journal of Clinical Oncology. 9(2). 117–125. 13 indexed citations
11.
Erhardt, K, et al.. (1986). DNA distribution pattern in intestinal carcinoid tumors. World Journal of Surgery. 10(4). 548–553. 18 indexed citations
12.
Erhardt, K, et al.. (1986). Comparison Between Histologic Type, Estrogen Receptor, and Nuclear DNA Content in Mammary Carcinoma. American Journal of Clinical Oncology. 9(1). 83–89. 10 indexed citations
13.
Falkmer, Sture, K Erhardt, Gert Auer, H. Mårtensson, & Anders Nobin. (1986). Patterns of DNA Distribution and Neurohormone Immunoreactivity in the Tumour Cells: Tools for the Histopathological Assessment of Gastro-Intestinal Carcinoids. Digestion. 35(1). 144–152. 8 indexed citations
14.
Erhardt, K & Gert Auer. (1986). MAMMARY CARCINOMA: COMPARISON OF DNA‐CONTENT IN THE PRIMARY TUMOR AND THE CORRESPONDING AXILLARY LYMPHNODE METASTASES. Acta Pathologica Microbiologica Scandinavica Series A Pathology. 94A(1-6). 29–34. 10 indexed citations
15.
Erhardt, K & Gert Auer. (1986). MAMMARY CARCINOMA: DNA ANALYSIS IN AREAS SHOWING DIFFERENT HISTOLOGICAL FEATURES IN THE SAME TUMOR. Acta Pathologica Microbiologica Scandinavica Series A Pathology. 94A(1-6). 21–28. 13 indexed citations
16.
Erhardt, K, Gert Auer, Gun Forsslund, et al.. (1985). Combined morphologic and cytochemical grading of serous ovarian tumors. American Journal of Obstetrics and Gynecology. 151(3). 356–361. 11 indexed citations
17.
Erhardt, K, et al.. (1985). Nuclear DNA in histologic sections from squamous-cell carcinoma and adenocarcinoma of the lung.. PubMed. 7(2). 153–8. 4 indexed citations
18.
Auer, Gert, Anders Fallenius, K Erhardt, & Birgitta Sundelin. (1984). Progression of mammary adenocarcinomas as reflected by nuclear DNA content. Cytometry. 5(4). 420–425. 58 indexed citations
19.
Erhardt, K, et al.. (1984). Prognostic significance of nuclear DNA content in serous ovarian tumors.. PubMed. 44(5). 2198–202. 89 indexed citations
20.
Forsslund, Gun, Björn Cedermark, U Öhman, et al.. (1984). The significance of DNA distribution pattern in rectal carcinoma. Diseases of the Colon & Rectum. 27(9). 579–584. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026